• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, November 21, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Alzheimer’s therapy may help overcome opioid addiction

Bioengineer by Bioengineer
June 5, 2019
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Clinical trial results reveal that a medication used to treat Alzheimer’s disease may also be an effective therapy for individuals addicted to opioids. The findings are published in The American Journal on Addictions.

The medication, called galantamine, is thought to have a dual mechanism of action–it increases levels of a chemical messenger called acetylcholine in the brain and also binds to nicotinic receptors, which play a role in addiction to nicotine and other substances.

Participants who took galantamine had fewer urine samples that were positive for opioids compared with those who took placebo, which corroborated with self-reported abstinence in those who took galantamine. Also, participants who used opioids during follow-up took longer to do so if they were in the galantamine group.

“My colleagues and I are excited about these preliminary findings, as they could point to new strategies for helping those with opioid use disorder. We hope to pursue this in future research,” said lead author Kathleen Carroll, PhD, of the Yale University School of Medicine.

###

Media Contact
Penny Smith
newsroom@wiley.com
http://dx.doi.org/10.1111/ajad.12904

Tags: AddictionDrugsMedicine/HealthPublic Health
Share13Tweet8Share2ShareShareShare2

Related Posts

RSV Hospitalizations Rose in Second Year Following Infant Nirsevimab Immunization

RSV Hospitalizations Rose in Second Year Following Infant Nirsevimab Immunization

November 21, 2026
Reduced Chemotherapy Protocol Achieves High Survival in Pediatric Unilateral Retinoblastoma Trial

Reduced Chemotherapy Protocol Achieves High Survival in Pediatric Unilateral Retinoblastoma Trial

November 21, 2026

Ultrasound Cervical Length Accurately Predicts Early Spontaneous Preterm Birth

November 21, 2026

Exercise Self-Efficacy Most Strongly Predicts Intentions Among Fitness Center Users

November 21, 2026
Please login to join discussion

POPULAR NEWS

  • Synthetic Microbial Communities Offer New Pathways for Climate Resilient Forest Management

    Synthetic Microbial Communities Offer New Pathways for Climate Resilient Forest Management

    29 shares
    Share 12 Tweet 7
  • Gut Microbiota Composition Predicts Systemic Inflammation Better Than Chronological Age

    29 shares
    Share 12 Tweet 7
  • Citrus Transcription Factor CsHAT14 Regulates Chlorophyll Breakdown and Fruit Degreening

    29 shares
    Share 12 Tweet 7
  • Topical Timolol Linked to Clinically Significant Bradyarrhythmias in Systematic Review

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

RSV Hospitalizations Rose in Second Year Following Infant Nirsevimab Immunization

Reduced Chemotherapy Protocol Achieves High Survival in Pediatric Unilateral Retinoblastoma Trial

Ultrasound Cervical Length Accurately Predicts Early Spontaneous Preterm Birth

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.